Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer
- Author
- R PARIDAENS, L DIRIX, C LOHRISCH, L BEEX, M NOOIJ, D CAMERON, L BIGANZOLI, T CUFER, Luc Duchateau (UGent) , A HAMILTON, JP LOBELLE and M PICCART
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-209732
- MLA
- PARIDAENS, R., et al. “Mature Results of a Randomized Phase II Multicenter Study of Exemestane versus Tamoxifen as First-Line Hormone Therapy for Postmenopausal Women with Metastatic Breast Cancer.” ANNALS OF ONCOLOGY, vol. 14, no. 9, 2003, pp. 1391–98.
- APA
- PARIDAENS, R., DIRIX, L., LOHRISCH, C., BEEX, L., NOOIJ, M., CAMERON, D., … PICCART, M. (2003). Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. ANNALS OF ONCOLOGY, 14(9), 1391–1398.
- Chicago author-date
- PARIDAENS, R, L DIRIX, C LOHRISCH, L BEEX, M NOOIJ, D CAMERON, L BIGANZOLI, et al. 2003. “Mature Results of a Randomized Phase II Multicenter Study of Exemestane versus Tamoxifen as First-Line Hormone Therapy for Postmenopausal Women with Metastatic Breast Cancer.” ANNALS OF ONCOLOGY 14 (9): 1391–98.
- Chicago author-date (all authors)
- PARIDAENS, R, L DIRIX, C LOHRISCH, L BEEX, M NOOIJ, D CAMERON, L BIGANZOLI, T CUFER, Luc Duchateau, A HAMILTON, JP LOBELLE, and M PICCART. 2003. “Mature Results of a Randomized Phase II Multicenter Study of Exemestane versus Tamoxifen as First-Line Hormone Therapy for Postmenopausal Women with Metastatic Breast Cancer.” ANNALS OF ONCOLOGY 14 (9): 1391–1398.
- Vancouver
- 1.PARIDAENS R, DIRIX L, LOHRISCH C, BEEX L, NOOIJ M, CAMERON D, et al. Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. ANNALS OF ONCOLOGY. 2003;14(9):1391–8.
- IEEE
- [1]R. PARIDAENS et al., “Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer,” ANNALS OF ONCOLOGY, vol. 14, no. 9, pp. 1391–1398, 2003.
@article{209732,
author = {{PARIDAENS, R and DIRIX, L and LOHRISCH, C and BEEX, L and NOOIJ, M and CAMERON, D and BIGANZOLI, L and CUFER, T and Duchateau, Luc and HAMILTON, A and LOBELLE, JP and PICCART, M}},
issn = {{0923-7534}},
journal = {{ANNALS OF ONCOLOGY}},
language = {{eng}},
number = {{9}},
pages = {{1391--1398}},
title = {{Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer}},
volume = {{14}},
year = {{2003}},
}